CN Stock MarketDetailed Quotes

600993 Mayinglong Pharmaceutical Group

Watchlist
  • 25.59
  • -0.03-0.12%
Trading Nov 5 10:15 CST
11.03BMarket Cap22.87P/E (TTM)

Mayinglong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
16.44%2.33B
17.62%2.44B
9.32%2.41B
19.83%2.99B
-2.79%2B
-9.19%2.08B
19.98%2.21B
2.59%2.49B
41.95%2.06B
19.68%2.29B
Transactional financial assets
-19.89%684.57M
-21.78%705.41M
-22.93%615.12M
-90.62%63.29M
-3.85%854.55M
2,110.41%901.83M
64.33%798.13M
536.04%674.35M
45.42%888.82M
-57.16%40.8M
Notes receivable and accounts receivable
-31.72%382.33M
-23.37%357.09M
-27.96%313.71M
-12.43%280.16M
52.16%559.91M
5.40%466.02M
0.08%435.48M
89.22%319.94M
18.37%367.96M
6.82%442.16M
-Notes receivable
32.67%71.79M
108.79%93.95M
-0.67%81.6M
-53.38%33.79M
7.75%54.11M
-52.99%45M
6.63%82.15M
58.77%72.48M
-45.64%50.22M
-58.12%95.7M
-Accounts receivable
-38.60%310.54M
-37.50%263.14M
-34.31%232.11M
-0.44%246.37M
59.18%505.8M
21.52%421.03M
-1.33%353.34M
100.48%247.47M
45.44%317.75M
86.87%346.46M
Other receivables (including interest and dividends)
24.55%65.87M
18.53%70.63M
-23.99%56.07M
-31.72%25.37M
-14.37%52.89M
-12.22%59.59M
40.54%73.78M
96.60%37.16M
6.35%61.76M
48.38%67.88M
-Dividend receivable
----
----
----
----
----
----
----
--8.6M
----
----
-Other receivable
----
18.53%70.63M
----
----
----
-12.22%59.59M
----
51.08%28.56M
----
48.38%67.88M
Advance payment
-14.60%65.9M
-10.36%67.35M
-10.38%63.61M
-21.99%53.39M
-27.43%77.17M
-28.03%75.14M
-28.65%70.98M
-1.03%68.44M
16.20%106.33M
45.08%104.4M
Inventories
11.96%316.06M
-14.91%291.91M
-15.09%291.25M
-18.66%273.48M
-16.64%282.3M
2.74%343.07M
24.53%343.01M
7.10%336.2M
14.05%338.65M
20.64%333.94M
Receivable financing
60.13%112.32M
31.93%124.84M
72.74%156.67M
-39.24%54.5M
38.16%70.14M
-6.49%94.63M
-20.87%90.7M
21.57%89.7M
-33.01%50.77M
-41.39%101.19M
Assets held for sale
--150K
--150K
-99.22%150K
-99.66%150K
----
----
200.80%19.34M
578.96%43.66M
--6.43M
--6.43M
Other current assets
-85.68%31.99M
-82.91%37.84M
-77.55%32.54M
-79.63%33.14M
37.08%223.46M
34.50%221.38M
-15.89%144.96M
-6.13%162.71M
-67.21%163.01M
-50.10%164.59M
Total current assets
-3.21%3.99B
-3.32%4.1B
-5.76%3.94B
-10.75%3.77B
1.96%4.12B
19.46%4.24B
20.17%4.19B
25.72%4.23B
19.18%4.04B
6.96%3.55B
Non Current assets
Other non-current financial assets
-23.85%13.42M
-22.49%13.66M
0.91%17.78M
0.91%17.78M
-6.75%17.62M
-6.75%17.62M
-6.75%17.62M
-6.75%17.62M
7.02%18.89M
7.02%18.89M
Long-term equity investment
3.57%137.81M
1.58%137.71M
1.70%136.42M
0.89%135.05M
-26.22%133.07M
-24.89%135.57M
-32.25%134.15M
-15.22%133.86M
14.55%180.36M
13.93%180.5M
Fixed assets
----
-2.55%296.84M
----
----
----
-4.88%304.6M
----
0.14%331.19M
----
3.42%320.23M
Constru in process
----
233.86%252.32M
----
----
----
454.92%75.58M
----
193.93%25.71M
----
-51.81%13.62M
Intangible assets
169.57%87.47M
157.72%87.84M
147.56%88.07M
141.73%90.11M
-12.61%32.45M
-9.82%34.08M
-6.49%35.57M
1.01%37.28M
11.14%37.13M
13.87%37.8M
Development expenditure
62.68%97.44M
52.16%83.35M
57.47%78.52M
66.97%71.66M
58.04%59.9M
61.31%54.77M
58.46%49.87M
41.66%42.92M
21.08%37.9M
10.87%33.96M
Goodwill
0.00%25.26M
0.00%25.26M
0.00%25.26M
0.00%25.26M
0.00%25.26M
0.00%25.26M
0.00%25.26M
0.00%25.26M
0.00%25.26M
0.00%25.26M
Long deferred expense
-47.39%6.66M
-47.92%7.69M
-44.24%9.29M
-54.94%10.63M
-46.12%12.66M
-41.77%14.77M
-36.48%16.67M
-16.12%23.6M
-38.22%23.5M
-35.83%25.37M
Deferred tax assets
-11.75%47.03M
6.47%54.85M
-9.70%48.59M
-15.25%49.46M
121.39%53.29M
89.37%51.52M
128.98%53.81M
169.73%58.36M
16.70%24.07M
43.16%27.21M
Usufruct assets
-22.25%108.37M
-19.93%114.79M
-20.15%120.74M
-20.25%126.36M
-16.66%139.39M
59.70%143.36M
57.42%151.2M
56.92%158.44M
77.98%167.25M
11.72%89.77M
Other non current assets
63.65%21.23M
62.40%22.92M
55.55%19.61M
175.76%22.46M
33.76%12.97M
54.15%14.11M
-13.93%12.61M
29.93%8.14M
418.49%9.7M
315.54%9.16M
Total non current assets
27.73%1.14B
25.94%1.1B
24.39%1.07B
22.68%1.06B
3.55%889.67M
11.45%871.26M
6.61%858.65M
12.62%862.38M
13.72%859.19M
5.05%781.76M
Total assets
2.28%5.12B
1.67%5.19B
-0.63%5.01B
-5.08%4.83B
2.24%5.01B
18.01%5.11B
17.62%5.04B
23.29%5.09B
18.19%4.9B
6.61%4.33B
Liabilities
Current liabilities
Short term loan
-8.89%32.8M
-32.45%35.8M
-11.70%46.8M
-48.01%45.8M
-59.14%36M
39.47%53M
-39.91%53M
0.11%88.1M
-3.19%88.1M
-53.66%38M
Notes payable and accounts payable
77.17%371.48M
25.22%362.11M
-3.38%276.34M
1.74%289.69M
-15.90%209.68M
38.44%289.18M
7.81%286.01M
81.56%284.74M
70.43%249.34M
15.81%208.89M
-Notes payable
360.42%181.63M
32.11%151.4M
-60.30%49.03M
-40.21%79.67M
-43.94%39.45M
371.77%114.6M
251.88%123.51M
347.55%133.26M
1,082.12%70.36M
-39.10%24.29M
-Accounts payable
11.53%189.85M
20.69%210.71M
39.88%227.31M
38.65%210.01M
-4.88%170.23M
-5.43%174.58M
-29.41%162.5M
19.23%151.47M
27.52%178.97M
31.41%184.6M
Contract liabilities
-13.01%68.37M
43.48%85.83M
57.94%131.52M
-10.60%91.86M
-28.98%78.59M
-49.17%59.82M
-35.84%83.27M
16.53%102.75M
-54.65%110.66M
-36.11%117.68M
Salaries payable
227.31%22.02M
221.64%23.49M
112.54%18.9M
-22.13%23.72M
1.78%6.73M
14.50%7.3M
40.46%8.89M
-9.84%30.46M
21.86%6.61M
28.19%6.38M
Taxs payable
-15.30%118.03M
-2.49%102.78M
9.47%101.57M
-40.01%96.39M
-21.20%139.35M
-14.93%105.4M
-6.43%92.78M
-5.03%160.69M
21.84%176.84M
17.12%123.91M
Other payable (including interest and dividends)
52.43%69.93M
27.80%282.99M
-13.61%78.37M
-44.30%80.49M
-36.54%45.88M
-9.97%221.44M
14.64%90.72M
49.87%144.5M
-20.50%72.29M
18.99%245.95M
-Dividend payable
14.32%1.97M
17.27%178.69M
201.17%4.55M
14.41%1.73M
14.41%1.73M
-0.23%152.38M
-19.19%1.51M
-80.89%1.51M
-80.89%1.51M
17.10%152.74M
-Other payable
----
51.03%104.3M
----
----
----
-25.91%69.06M
----
61.53%142.99M
----
22.21%93.22M
Hold and for sell liabilities
----
----
----
----
----
----
--3.86M
----
----
----
Non current liabilities due within one year
276.13%131.67M
-26.66%24.17M
21.04%33.36M
16.98%32.91M
31.71%35.01M
38.14%32.95M
29.01%27.56M
33.06%28.13M
162.66%26.58M
56.31%23.86M
Other current liabilities
45.23%20.54M
6.40%20.26M
-9.64%18.06M
7.69%20.23M
-43.16%14.14M
-13.04%19.05M
24.40%19.99M
57.69%18.78M
-12.58%24.88M
7.28%21.9M
Total current liabilities
47.66%834.84M
18.94%937.44M
5.83%704.92M
-20.63%681.07M
-25.15%565.38M
0.20%788.15M
-5.57%666.08M
28.96%858.14M
-0.80%755.3M
-1.64%786.57M
Current liabilities
Long term loan
----
-72.58%109.7M
-75.62%99.9M
-75.00%100M
0.00%400M
--400M
--409.8M
--400M
--400M
----
Deferred tax liabilities
-16.87%26.37M
-19.37%26.11M
-22.89%27.34M
-19.11%28.61M
1,337.62%31.72M
1,321.03%32.38M
1,407.28%35.45M
1,307.97%35.37M
-17.44%2.21M
-14.73%2.28M
Long term deferred income
11.55%28.73M
17.70%30.8M
-2.82%26.03M
3.49%27.89M
-1.83%25.75M
-4.20%26.16M
-4.31%26.78M
-7.16%26.95M
74.34%26.23M
73.87%27.31M
Lease liabilities
-29.34%80.62M
-27.82%83.92M
-25.82%88.95M
-23.29%93.59M
-13.41%114.1M
76.55%116.26M
67.06%119.91M
66.65%122M
55.64%131.76M
1.12%65.85M
Other non current liabilities
-18.30%23.76M
-20.00%23.37M
-24.56%21.6M
-3.66%28.46M
26.05%29.08M
17.57%29.21M
4.72%28.63M
-30.55%29.54M
-21.05%23.07M
-5.01%24.85M
Total non current liabilities
-73.45%159.47M
-54.65%273.89M
-57.49%263.81M
-54.62%278.55M
2.98%600.65M
402.14%604.02M
379.37%620.57M
316.79%613.86M
310.04%583.27M
-0.01%120.29M
Total liabilities
-14.73%994.31M
-12.99%1.21B
-24.71%968.73M
-34.81%959.62M
-12.89%1.17B
53.52%1.39B
54.13%1.29B
81.12%1.47B
48.13%1.34B
-1.43%906.85M
Shareholders equity
Paid-in capital
0.00%431.05M
0.00%431.05M
0.00%431.05M
0.00%431.05M
0.00%431.05M
0.00%431.05M
0.00%431.05M
0.00%431.05M
0.00%431.05M
0.00%431.05M
Capital reserve funds
-47.86%29.23M
-53.17%29.13M
-53.70%28.86M
-48.87%51.51M
-45.25%56.06M
-40.00%62.2M
-40.74%62.34M
-4.24%100.74M
5.38%102.4M
-5.26%103.67M
Surplus reserve funds
0.00%295.29M
0.00%295.29M
0.00%295.29M
0.00%295.29M
0.00%295.29M
0.00%295.29M
0.00%295.29M
0.00%295.29M
0.00%295.29M
0.00%295.29M
Retained profit
10.54%3.24B
10.75%3.1B
10.57%3.16B
10.97%2.96B
12.66%2.93B
13.69%2.8B
15.24%2.85B
13.96%2.67B
16.15%2.6B
15.54%2.46B
Other composite income
-8.51%2.59M
-4.94%2.76M
21.73%2.66M
8.04%2.66M
7.52%2.83M
55.23%2.9M
85.49%2.19M
91.91%2.46M
72.46%2.64M
23.51%1.87M
Shareholders equity without minority interests
7.59%4B
7.45%3.86B
7.37%3.91B
6.96%3.74B
8.25%3.72B
9.00%3.59B
10.14%3.64B
10.19%3.49B
12.01%3.44B
10.97%3.29B
Minority interests
3.16%129.75M
-1.07%126.82M
15.37%130.45M
8.59%131.94M
-0.86%125.77M
-1.47%128.2M
-21.81%113.07M
-14.92%121.5M
-27.96%126.86M
-25.18%130.11M
Other items effecting shareholder equity
----
----
---0.01
----
----
----
----
----
----
----
Total shareholder equity
7.44%4.13B
7.16%3.98B
7.61%4.04B
7.02%3.87B
7.93%3.84B
8.60%3.72B
8.80%3.76B
9.11%3.62B
9.84%3.56B
8.97%3.42B
Total liabilityies and equity
2.28%5.12B
1.67%5.19B
-0.63%5.01B
-5.08%4.83B
2.24%5.01B
18.01%5.11B
17.62%5.04B
23.29%5.09B
18.19%4.9B
6.61%4.33B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 16.44%2.33B17.62%2.44B9.32%2.41B19.83%2.99B-2.79%2B-9.19%2.08B19.98%2.21B2.59%2.49B41.95%2.06B19.68%2.29B
Transactional financial assets -19.89%684.57M-21.78%705.41M-22.93%615.12M-90.62%63.29M-3.85%854.55M2,110.41%901.83M64.33%798.13M536.04%674.35M45.42%888.82M-57.16%40.8M
Notes receivable and accounts receivable -31.72%382.33M-23.37%357.09M-27.96%313.71M-12.43%280.16M52.16%559.91M5.40%466.02M0.08%435.48M89.22%319.94M18.37%367.96M6.82%442.16M
-Notes receivable 32.67%71.79M108.79%93.95M-0.67%81.6M-53.38%33.79M7.75%54.11M-52.99%45M6.63%82.15M58.77%72.48M-45.64%50.22M-58.12%95.7M
-Accounts receivable -38.60%310.54M-37.50%263.14M-34.31%232.11M-0.44%246.37M59.18%505.8M21.52%421.03M-1.33%353.34M100.48%247.47M45.44%317.75M86.87%346.46M
Other receivables (including interest and dividends) 24.55%65.87M18.53%70.63M-23.99%56.07M-31.72%25.37M-14.37%52.89M-12.22%59.59M40.54%73.78M96.60%37.16M6.35%61.76M48.38%67.88M
-Dividend receivable ------------------------------8.6M--------
-Other receivable ----18.53%70.63M-------------12.22%59.59M----51.08%28.56M----48.38%67.88M
Advance payment -14.60%65.9M-10.36%67.35M-10.38%63.61M-21.99%53.39M-27.43%77.17M-28.03%75.14M-28.65%70.98M-1.03%68.44M16.20%106.33M45.08%104.4M
Inventories 11.96%316.06M-14.91%291.91M-15.09%291.25M-18.66%273.48M-16.64%282.3M2.74%343.07M24.53%343.01M7.10%336.2M14.05%338.65M20.64%333.94M
Receivable financing 60.13%112.32M31.93%124.84M72.74%156.67M-39.24%54.5M38.16%70.14M-6.49%94.63M-20.87%90.7M21.57%89.7M-33.01%50.77M-41.39%101.19M
Assets held for sale --150K--150K-99.22%150K-99.66%150K--------200.80%19.34M578.96%43.66M--6.43M--6.43M
Other current assets -85.68%31.99M-82.91%37.84M-77.55%32.54M-79.63%33.14M37.08%223.46M34.50%221.38M-15.89%144.96M-6.13%162.71M-67.21%163.01M-50.10%164.59M
Total current assets -3.21%3.99B-3.32%4.1B-5.76%3.94B-10.75%3.77B1.96%4.12B19.46%4.24B20.17%4.19B25.72%4.23B19.18%4.04B6.96%3.55B
Non Current assets
Other non-current financial assets -23.85%13.42M-22.49%13.66M0.91%17.78M0.91%17.78M-6.75%17.62M-6.75%17.62M-6.75%17.62M-6.75%17.62M7.02%18.89M7.02%18.89M
Long-term equity investment 3.57%137.81M1.58%137.71M1.70%136.42M0.89%135.05M-26.22%133.07M-24.89%135.57M-32.25%134.15M-15.22%133.86M14.55%180.36M13.93%180.5M
Fixed assets -----2.55%296.84M-------------4.88%304.6M----0.14%331.19M----3.42%320.23M
Constru in process ----233.86%252.32M------------454.92%75.58M----193.93%25.71M-----51.81%13.62M
Intangible assets 169.57%87.47M157.72%87.84M147.56%88.07M141.73%90.11M-12.61%32.45M-9.82%34.08M-6.49%35.57M1.01%37.28M11.14%37.13M13.87%37.8M
Development expenditure 62.68%97.44M52.16%83.35M57.47%78.52M66.97%71.66M58.04%59.9M61.31%54.77M58.46%49.87M41.66%42.92M21.08%37.9M10.87%33.96M
Goodwill 0.00%25.26M0.00%25.26M0.00%25.26M0.00%25.26M0.00%25.26M0.00%25.26M0.00%25.26M0.00%25.26M0.00%25.26M0.00%25.26M
Long deferred expense -47.39%6.66M-47.92%7.69M-44.24%9.29M-54.94%10.63M-46.12%12.66M-41.77%14.77M-36.48%16.67M-16.12%23.6M-38.22%23.5M-35.83%25.37M
Deferred tax assets -11.75%47.03M6.47%54.85M-9.70%48.59M-15.25%49.46M121.39%53.29M89.37%51.52M128.98%53.81M169.73%58.36M16.70%24.07M43.16%27.21M
Usufruct assets -22.25%108.37M-19.93%114.79M-20.15%120.74M-20.25%126.36M-16.66%139.39M59.70%143.36M57.42%151.2M56.92%158.44M77.98%167.25M11.72%89.77M
Other non current assets 63.65%21.23M62.40%22.92M55.55%19.61M175.76%22.46M33.76%12.97M54.15%14.11M-13.93%12.61M29.93%8.14M418.49%9.7M315.54%9.16M
Total non current assets 27.73%1.14B25.94%1.1B24.39%1.07B22.68%1.06B3.55%889.67M11.45%871.26M6.61%858.65M12.62%862.38M13.72%859.19M5.05%781.76M
Total assets 2.28%5.12B1.67%5.19B-0.63%5.01B-5.08%4.83B2.24%5.01B18.01%5.11B17.62%5.04B23.29%5.09B18.19%4.9B6.61%4.33B
Liabilities
Current liabilities
Short term loan -8.89%32.8M-32.45%35.8M-11.70%46.8M-48.01%45.8M-59.14%36M39.47%53M-39.91%53M0.11%88.1M-3.19%88.1M-53.66%38M
Notes payable and accounts payable 77.17%371.48M25.22%362.11M-3.38%276.34M1.74%289.69M-15.90%209.68M38.44%289.18M7.81%286.01M81.56%284.74M70.43%249.34M15.81%208.89M
-Notes payable 360.42%181.63M32.11%151.4M-60.30%49.03M-40.21%79.67M-43.94%39.45M371.77%114.6M251.88%123.51M347.55%133.26M1,082.12%70.36M-39.10%24.29M
-Accounts payable 11.53%189.85M20.69%210.71M39.88%227.31M38.65%210.01M-4.88%170.23M-5.43%174.58M-29.41%162.5M19.23%151.47M27.52%178.97M31.41%184.6M
Contract liabilities -13.01%68.37M43.48%85.83M57.94%131.52M-10.60%91.86M-28.98%78.59M-49.17%59.82M-35.84%83.27M16.53%102.75M-54.65%110.66M-36.11%117.68M
Salaries payable 227.31%22.02M221.64%23.49M112.54%18.9M-22.13%23.72M1.78%6.73M14.50%7.3M40.46%8.89M-9.84%30.46M21.86%6.61M28.19%6.38M
Taxs payable -15.30%118.03M-2.49%102.78M9.47%101.57M-40.01%96.39M-21.20%139.35M-14.93%105.4M-6.43%92.78M-5.03%160.69M21.84%176.84M17.12%123.91M
Other payable (including interest and dividends) 52.43%69.93M27.80%282.99M-13.61%78.37M-44.30%80.49M-36.54%45.88M-9.97%221.44M14.64%90.72M49.87%144.5M-20.50%72.29M18.99%245.95M
-Dividend payable 14.32%1.97M17.27%178.69M201.17%4.55M14.41%1.73M14.41%1.73M-0.23%152.38M-19.19%1.51M-80.89%1.51M-80.89%1.51M17.10%152.74M
-Other payable ----51.03%104.3M-------------25.91%69.06M----61.53%142.99M----22.21%93.22M
Hold and for sell liabilities --------------------------3.86M------------
Non current liabilities due within one year 276.13%131.67M-26.66%24.17M21.04%33.36M16.98%32.91M31.71%35.01M38.14%32.95M29.01%27.56M33.06%28.13M162.66%26.58M56.31%23.86M
Other current liabilities 45.23%20.54M6.40%20.26M-9.64%18.06M7.69%20.23M-43.16%14.14M-13.04%19.05M24.40%19.99M57.69%18.78M-12.58%24.88M7.28%21.9M
Total current liabilities 47.66%834.84M18.94%937.44M5.83%704.92M-20.63%681.07M-25.15%565.38M0.20%788.15M-5.57%666.08M28.96%858.14M-0.80%755.3M-1.64%786.57M
Current liabilities
Long term loan -----72.58%109.7M-75.62%99.9M-75.00%100M0.00%400M--400M--409.8M--400M--400M----
Deferred tax liabilities -16.87%26.37M-19.37%26.11M-22.89%27.34M-19.11%28.61M1,337.62%31.72M1,321.03%32.38M1,407.28%35.45M1,307.97%35.37M-17.44%2.21M-14.73%2.28M
Long term deferred income 11.55%28.73M17.70%30.8M-2.82%26.03M3.49%27.89M-1.83%25.75M-4.20%26.16M-4.31%26.78M-7.16%26.95M74.34%26.23M73.87%27.31M
Lease liabilities -29.34%80.62M-27.82%83.92M-25.82%88.95M-23.29%93.59M-13.41%114.1M76.55%116.26M67.06%119.91M66.65%122M55.64%131.76M1.12%65.85M
Other non current liabilities -18.30%23.76M-20.00%23.37M-24.56%21.6M-3.66%28.46M26.05%29.08M17.57%29.21M4.72%28.63M-30.55%29.54M-21.05%23.07M-5.01%24.85M
Total non current liabilities -73.45%159.47M-54.65%273.89M-57.49%263.81M-54.62%278.55M2.98%600.65M402.14%604.02M379.37%620.57M316.79%613.86M310.04%583.27M-0.01%120.29M
Total liabilities -14.73%994.31M-12.99%1.21B-24.71%968.73M-34.81%959.62M-12.89%1.17B53.52%1.39B54.13%1.29B81.12%1.47B48.13%1.34B-1.43%906.85M
Shareholders equity
Paid-in capital 0.00%431.05M0.00%431.05M0.00%431.05M0.00%431.05M0.00%431.05M0.00%431.05M0.00%431.05M0.00%431.05M0.00%431.05M0.00%431.05M
Capital reserve funds -47.86%29.23M-53.17%29.13M-53.70%28.86M-48.87%51.51M-45.25%56.06M-40.00%62.2M-40.74%62.34M-4.24%100.74M5.38%102.4M-5.26%103.67M
Surplus reserve funds 0.00%295.29M0.00%295.29M0.00%295.29M0.00%295.29M0.00%295.29M0.00%295.29M0.00%295.29M0.00%295.29M0.00%295.29M0.00%295.29M
Retained profit 10.54%3.24B10.75%3.1B10.57%3.16B10.97%2.96B12.66%2.93B13.69%2.8B15.24%2.85B13.96%2.67B16.15%2.6B15.54%2.46B
Other composite income -8.51%2.59M-4.94%2.76M21.73%2.66M8.04%2.66M7.52%2.83M55.23%2.9M85.49%2.19M91.91%2.46M72.46%2.64M23.51%1.87M
Shareholders equity without minority interests 7.59%4B7.45%3.86B7.37%3.91B6.96%3.74B8.25%3.72B9.00%3.59B10.14%3.64B10.19%3.49B12.01%3.44B10.97%3.29B
Minority interests 3.16%129.75M-1.07%126.82M15.37%130.45M8.59%131.94M-0.86%125.77M-1.47%128.2M-21.81%113.07M-14.92%121.5M-27.96%126.86M-25.18%130.11M
Other items effecting shareholder equity -----------0.01----------------------------
Total shareholder equity 7.44%4.13B7.16%3.98B7.61%4.04B7.02%3.87B7.93%3.84B8.60%3.72B8.80%3.76B9.11%3.62B9.84%3.56B8.97%3.42B
Total liabilityies and equity 2.28%5.12B1.67%5.19B-0.63%5.01B-5.08%4.83B2.24%5.01B18.01%5.11B17.62%5.04B23.29%5.09B18.19%4.9B6.61%4.33B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data